Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Patients with diabetic macular edema who were switched to aflibercept after having been
treated with bevacizumab or ranibizumab were retrospectively reviewed to assess for visual
acuity and anatomic outcomes.